| Year | 🟢 Light | 🎯 Fair | ⚡ Risk+ | S&P 500 | Top pick |
|---|---|---|---|---|---|
| 2025 | +41% | +41% | +53% | +16% | WDC +282% |
| 2024 | +19% | +49% | +24% | +23% | APP +713% |
| 2023 | +45% | +88% | +78% | +24% | COIN +391% |
| 2022 | -30% | -23% | -19% | -19% | OXY +117% |
| 2021 | +28% | +23% | +34% | +27% | MRNA +143% |
| 2020 | +60% | +37% | +78% | +16% | TSLA +743% |
| 2019 | +25% | +34% | +33% | +29% | LITE +89% |
| 2018 | -8% | -9% | -3% | -6% | BSX +43% |
| 2017 | +31% | +24% | +30% | +19% | VRTX +103% |
| 2016 | +15% | +16% | +18% | +10% | TRGP +107% |
| 2015 | 0% | +6% | +6% | -1% | GPN +60% |
📊 See the full 11-year backtest →
Yes: for each year since 2015 we show the 20 stocks the JPI Fair method would have picked on Jan 1 (using only prior info), and their real 12-month return. Click a year in the table.
No. Over 11 years it beat the S&P 500 8 times. Some years are negative (2018, 2022). It's lumpy — the edge shows over time, not every year.
On the Backtests page: the JPI Fair method returned +26%/yr over 11 years (2015-2025) vs +12.6% for the S&P 500, with the per-method detail and risk/return ratio.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.